Skip to main content
. 2023 May 30;381:e074678. doi: 10.1136/bmj-2022-074678

Table 2.

Final model hazard ratios and β coefficients before shrinkage

Predictors Adjusted hazard ratio (95% CI)* β coefficient
Age (years) 1.00 (1.00 to 1.01) −0.0005886
Female sex 0.96 (0.83 to1.11) −0.0412595
Methotrexate dose (mg/day) 1.01 (0.93 to 1.09) 0.0111752
Body mass index 0.99 (0.98 to 1.00) −0.0100983
Smoking status:
 Non-smoker, NR, former smoker Reference -
 Current smoker 1.06 (0.89 to 1.25) 0.0545787
Alcohol consumption (units/week):
 Non-drinker Reference -
 Low (1-14) 0.93 (0.73 to 1.17) −0.0745235
 Moderate (15-21) 0.79 (0.52 to 1.19) −0.2376144
 Hazardous (>21) 1.11 (0.79 to 1.56) 0.1062592
 Former drinker 0.95 (0.74 to 1.22) −0.0555338
Inflammatory conditions:
 Rheumatoid arthritis Reference -
 Psoriasis or psoriatic arthritis 1.14 (0.96 to 1.36) 0.1339634
 Polymyalgia rheumatica or giant cell arteritis 0.99 (0.75 to 1.31) −0.0111359
 Connective tissue diseases* 1.34 (0.87 to 2.07) 0.2919058
 Other seronegative spondyloarthritis† 1.30 (0.91 to 1.87) 0.2636568
Comorbidities:
 Diabetes mellitus 1.25 (1.02 to 1.53) 0.2225364
 Chronic kidney disease stage 3 2.01 (1.63 to 2.49) 0.7005654
Drugs:
 Hydroxychloroquine 0.90 (0.72 to 1.11) −0.1073611
 5-aminosalicylate or sulfasalazine 0.92 (0.76 to 1.12) −0.0791611
 Other glucocorticoid sparing drugs‡ 1.11 (0.66 to 1.85) 0.1000699
 Statin 1.11 (0.93 to 1.32) 0.1021201
 NSAID or high dose aspirin (≥300 mg/day) 0.97 (0.83 to 1.12) −0.0334514
 Paracetamol (acetaminophen) 1.17 (0.98 to 1.40) 0.1608563
 Proton pump inhibitor 1.02 (0.88 to 1.18) 0.0170423
 Antiepileptic§ 1.68 (0.92 to 3.05) 0.5164347
Blood test abnormalities:
 Cytopenia or raised liver enzyme levels within first six months of first primary care methotrexate prescription 2.97 (2.57 to 3.41) 1.086389

NR=not recorded; NSAID=non-steroidal anti-inflammatory drug.

One unit of alcohol equals 10 mL or 8 g of pure alcohol.

*

Includes lupus, systemic sclerosis, myositis, and small vessel vasculitis.

Includes ankylosing spondylitis, reactive arthritis, and inflammatory bowel disease associated inflammatory arthritis.

Includes leflunomide, azathioprine, 6-mercaptopurine, ciclosporin, tacrolimus, and mycophenolate mofetil.

§

Includes carbamazepine, levetiracetam, and valproate.